These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37719010)

  • 1. Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study.
    Wang J; Zheng T; Liao Y; Geng S; Li J; Zhang Z; Shang D; Liu C; Yu P; Huang Y; Liu C; Liu Y; Liu S; Wang M; Liu D; Miao H; Li S; Zhang B; Huang A; Zhang Y; Qi X; Chen S
    Front Oncol; 2023; 13():1278295. PubMed ID: 37719010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: A multicenter study.
    Wang J; Zheng T; Liao Y; Geng S; Li J; Zhang Z; Shang D; Liu C; Yu P; Huang Y; Liu C; Liu Y; Liu S; Wang M; Liu D; Miao H; Li S; Zhang B; Huang A; Zhang Y; Qi X; Chen S
    Front Oncol; 2022; 12():986867. PubMed ID: 36408144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the Preoperative Assistant System Based on Machine Learning in Hepatocellular Carcinoma Resection.
    Lv S; Li S; Yu Z; Wang K; Qiao X; Gong D; Wu C
    J Healthc Eng; 2021; 2021():4757668. PubMed ID: 34608411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Radiomic machine learning and external validation based on 3.0T mpMRI for prediction of intraductal carcinoma of prostate with different proportion.
    Yang L; Li Z; Liang X; Xu J; Cai Y; Huang C; Zhang M; Yao J; Song B
    Front Oncol; 2024; 14():1401121. PubMed ID: 38634050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum:
    Xu S; Hu C; Jiang Z; Li G; Zhou B; Gao Z; Wang W; Yan S
    Front Oncol; 2023; 13():1251636. PubMed ID: 37637040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma.
    Mai RY; Lu HZ; Bai T; Liang R; Lin Y; Ma L; Xiang BD; Wu GB; Li LQ; Ye JZ
    Surgery; 2020 Oct; 168(4):643-652. PubMed ID: 32792098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection [Corrigendum].
    J Hepatocell Carcinoma; 2021; 8():1297-1298. PubMed ID: 34737984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Prediction of Microvascular Invasion and Its M2 Classification in Hepatocellular Carcinoma Based on Nomogram Analyses.
    Chen S; Wang C; Gu Y; Ruan R; Yu J; Wang S
    Front Oncol; 2022; 12():888008. PubMed ID: 35449582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental artificial neural network model to evaluate the preoperative safe limit of future liver remnant volume for HCC combined with clinically significant portal hypertension.
    Lu HZ; Mai RY; Wang XB; Chen J; Bai T; Ma L; Xiang BD; Cheng SQ; Guo WX; Li LQ; Ye JZ
    Future Oncol; 2022 Jul; 18(21):2683-2694. PubMed ID: 35699041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
    Cai S; Lin X; Sun Y; Lin Z; Wang X; Lin N; Zhao X
    Eur J Radiol; 2022 Sep; 154():110449. PubMed ID: 35901599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma.
    Dong Y; Liu X; Jiang B; Wei S; Xiang B; Liao R; Wang Q; He X
    Front Oncol; 2023; 13():1253552. PubMed ID: 37719011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():801970. PubMed ID: 34900749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning.
    Saito A; Toyoda H; Kobayashi M; Koiwa Y; Fujii H; Fujita K; Maeda A; Kaneoka Y; Hazama S; Nagano H; Mirza AH; Graf HP; Cosatto E; Murakami Y; Kuroda M
    Mod Pathol; 2021 Feb; 34(2):417-425. PubMed ID: 32948835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of preoperative two-dimensional shear wave elastography, indocyanine green clearance test and biomarkers for post hepatectomy liver failure prediction in patients with hepatocellular carcinoma.
    Fu R; Qiu T; Ling W; Lu Q; Luo Y
    BMC Gastroenterol; 2021 Mar; 21(1):142. PubMed ID: 33789567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma.
    Váncza L; Karászi K; Péterfia B; Turiák L; Dezső K; Sebestyén A; Reszegi A; Petővári G; Kiss A; Schaff Z; Baghy K; Kovalszky I
    Front Oncol; 2023; 13():1203745. PubMed ID: 37152016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion.
    Tsujita Y; Sofue K; Komatsu S; Yamaguchi T; Ueshima E; Ueno Y; Kanda T; Okada T; Nogami M; Yamaguchi M; Tsurusaki M; Hori M; Fukumoto T; Murakami T
    Eur J Radiol; 2020 Sep; 130():109189. PubMed ID: 32784077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():979968. PubMed ID: 36072794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of post-hepatectomy liver failure and long-term prognosis after curative resection of hepatocellular carcinoma using liver stiffness measurement.
    Chen X; Kuang M; Hu ZH; Peng YH; Wang N; Luo H; Yang P
    Arab J Gastroenterol; 2022 May; 23(2):82-88. PubMed ID: 35120839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.